Ceragenix Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile
Summary
Global Market Direct’s Ceragenix Pharmaceuticals, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Ceragenix Pharmaceuticals, Inc. (Ceragenix) is a medical device company focused on infectious diseases and dermatology. It has two technology platforms namely Ceragenins for the treatment of infectious disease; and Barrier Repair for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders, and others. The company is head quartered in Colorado, United States. The company’s Ceragenin technology covers the composition of matter and use of a broad class of small molecule, positively charged aminosterol compounds.
And More inside the report…
Recent Developments
Oct 26, 2009: Second Partner To Negotiate Licensing Terms For CeraShield Antimicrobial Coating Application
Jul 27, 2009: Ceragenix, Megapharm Seal Distribution, Supply Agreement
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Report HighlightsThe following companies are the major competitors of Ceragenix Pharmaceuticals, Inc.:
Inhibitex, Inc.
Helix BioMedix, Inc.
Angiotech Pharmaceuticals, Inc.
[Studien Infos ausblenden]